Table 1. Transplant risk groups in CML.

Class	Phase	Comments
The Good	CML CP	Intolerant to TKI
		Not able to obtain TKI therapy
The Bad	CML CP	Resistant with T315I mutation
		Poor response to secondary TKI therapy
The Ugly	CML AP	Treat with TKI until a donor is found
	CML BC